title: [Treatment of trigeminal neuralgia with glycerol injection at the gasserian ganglion].
abstract: Gasserian ganglion neurolysis with glycerol injected percutaneously through the foramen ovale continues to be widely used. Its long-term efficacy on pain is proportional to the degree of postoperative hypoesthesia. The advantage is low cost. The disadvantage is essentially the difficulty in controlling diffusion outside the Meckel cavity. Subsequently its effects are somewhat random and potential complications are difficult to prevent reliably.
authors.affiliation: Service de neurochirurgie A, hôpital neurologique Pierre-Wertheimer, groupement hospitalier Est, 69003 Lyon, France. marc.sindou@chu-lyon.fr
authors.forename: M
authors.initials: M
authors.lastname: Sindou
authors.forename: M
authors.initials: M
authors.lastname: Tatli
mesh_terms: D054085:Foramen Ovale; D005990:Glycerol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006987:Hypesthesia / Q000453:epidemiology / Q000209:etiology; D007267:Injections; D010146:Pain / Q000209:etiology; D059408:Pain Management; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D016896:Treatment Outcome; D012668:Trigeminal Ganglion / Q000502:physiology*; D014277:Trigeminal Neuralgia / Q000628:therapy*
chemical_list: D005990:Glycerol